Dr. Reddys Laboratories Launches Favipiravir In India
Hyderabad: Dr. Reddy&Rsquo;S Laboratories Ltd, Along With Its Subsidiaries Together Referred To As &Ldquo;Dr. Reddy&Rsquo;S&Rdquo; Today Announced The Launch Of Avigan&Reg; (Favipiravir) 200 Mg Tablets In India.The Launch Is Part Of The Global Licensing Agreement With Fujifilm Toyama Chemical Co. Ltd. That Grants Dr. Reddy&Rsquo;S The Exclusive Rights To Manufacture, Sell And Distribute Avigan (Favipiravir) 200 Mg Tablets In India.Avigan&Reg; (Favipiravir) Has Been Approved By The Drugs Controller General Of India (Dcgi) For The Treatment Of Patients With Mild To Moderate Covid-19 Disease.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
